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Abstract
Background This study aimed to compare the safety and
efficacy of laparoscopy and laparotomy in the surgical
treatment of early endometrial cancer, especially in obese
women.
Methods The results obtained after laparoscopic surgical
treatment of early endometrial cancer (International Fed-
eration of Gynecology and Obstetrics (FIGO) stage 1 or 2)
in patients between 1996 and 2007 were compared with an
age- and tumour-matched historical group of patients
treated with laparotomy between 1988 and 1996. All the
patients underwent hysterectomy, bilateral salpingo-ooph-
orectomy, and pelvic ± paraaortic lymphadenectomy.
Results Both groups included 120 patients with a preop-
erative diagnosis of early endometrial cancer. The post-
operative diagnosis was endometrial cancer stage 1 or 2 for
89% of the cases in both groups. The mean operating time
was 170 min for the laparotomy group compared with
178 min for the laparoscopy group (nonsignificant differ-
ence). The estimated intraoperative blood loss was signif-
icantly greater in the laparotomy group, and the hospital
stay was significantly shorter in the laparoscopy group.
Conclusions The results show that early endometrial
cancer can be treated effectively by laparoscopy. Because
of this study’s retrospective design, the results should be
interpreted with caution. However, the advantages of this
method for obese patients are evident. The age and weight
of these patients should not be used as a contraindication
for laparoscopy.
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Endometrial cancer is the most common gynecologic
malignancy in the United Stated, with approximately
40,000 new cases and 7,400 deaths attributed to this dis-
ease annually [1]. More than 1 in 20 female cancers in
Europe are endometrial cancer, with increasing trends
particularly among postmenopausal women in many
countries [2]. Changes in reproductive behavior, obesity,
and hormone replacement therapy may partially account
for the increase. Whereas obesity may place a patient at
increased risk for medical comorbidities including diabe-
tes, cardiovascular diseases, and osteoarthritis, it also is a
major risk factor for endometrial cancer. A recent study
reported that 68% of women with early-stage endometrial
cancer are obese [3].
The majority of endometrial cancer is without any
clinical or histologic sign of extrauterine cancer spread at
an early stage. Regional lymph nodes are the most common
site of occult metastatic disease in apparent early-stage
cancers.
Although endometrial cancer treatment often is via a
multimethod approach, the primary step in individualizing
a woman’s cancer care is surgery, and complete staging
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includes abdominal exploration, pelvic peritoneal cytology,
hysterectomy, bilateral salpingo-oophorectomy and pelvic
and aortic selective lymphadenectomy. Selective lym-
phadenectomy is necessary for individualization of adju-
vant therapy.
In the past decade, different studies have shown that
laparoscopic treatment of early-stage endometrial cancer is
an effective and economically efficient alternative to
classical laparotomy [4, 5]. The advantages of laparoscopy
demonstrated in other surgical interventions (e.g. shorter
hospital stay, quicker recovery, and lower risk of throm-
boembolic complications and postoperative infections)
have already been confirmed for laparoscopic treatment of
endometrial cancer [6, 7]. However, patients with endo-
metrial cancer often are both obese and elderly, conditions
that make the laparoscopic approach more difficult [8, 9].
Although findings have shown laparoscopy to be feasi-
ble and reproducible, it is associated with a steep learning
curve, most notably with regard to lymphadenectomy. In
addition, obesity and morbid obesity may increase the
technical issues encountered in this patient population.
The current study aimed to investigate the safety and
efficacy of laparoscopy compared with laparotomy for the
surgical treatment of early endometrial cancer and to
analyze whether obesity is a contraindication for laparo-
scopic lymphadenectomy.
Patients and methods
The charts of all patients with clinical early endometrial
cancer who underwent surgery between 1988 and 2007
were analyzed retrospectively. The inclusion criterion
specified a clinical diagnosis of endometrial cancer stage 1
or 2 according to the International Federation of Gyne-
cology and Obstetrics (FIGO) classification [10], which
means that patients preoperatively considered to have stage
1 or 2 disease were included in the study. Patients with a
previous malignancy and those who had undergone a
vaginal hysterectomy in the past were excluded.
A total of 120 patients were treated consecutively by
laparotomy from 1988 to 1996 and 120 patients by lapa-
roscopy from 1996 to 2007. Both techniques included
peritoneal washing, hysterectomy, bilateral salpingo-
oophorectomy, and pelvic ± paraaortic lymphadenectomy.
In the laparoscopy group, a total laparoscopic hyster-
ectomy was performed using a 308 laparoscope and a
uterine manipulator after coagulation of the fallopian tubes
if necessary. The uterus and the lymph nodes were evac-
uated vaginally, with the lymph nodes covered in an
Endobag (Endo Pouch, Ethikon, Guaynabo, PR, USA)
before removal. All the operations were performed by four
gynecologic oncologists.
The patients in the laparoscopy group were age- and
tumor-matched with the laparotomy group. Tumor match-
ing included tumor stage and histology with grading. Body
mass index (BMI) and operative outcome (operating time,
blood loss, number of recovered lymph nodes, length of
hospital stay) were comparable between the two groups.
For statistical evaluation, a t-test was applied using
GraphPad Prism version 4.00 for Windows (GraphPad
Software, San Diego, CA, USA). Alpha was set at 0.05 as a
cutoff value to avoid type 1 error.
Results
The data for 240 patients were analyzed, which resulted in
120 patients each in the laparoscopy and laparotomy
groups. The median age of the patients was 63 years
(range, 37–83 years) in the laparotomy group (group 1) and
62 years (range, 40–91 years) in the laparoscopy group
(group 2).
Table 1 shows the BMI, intraoperative blood loss, and
number of recovered lymph nodes. The intraoperative
blood loss was significantly greater in the laparotomy
group, with seven patients requiring transfusion. The BMI
was not significantly different between the two groups.
Lymph node metastases were confirmed in 5.8% of
group 1 compared with 6.7% of group 2 (nonsignificant
difference). The hospital stay was significantly longer in
group 1 (6 ± 4 days) than in group 2 (13.1 ± 3.7 days)
(p \ 0.001).
Although the analyzed period was the one in which
laparoscopy was introduced for this indication, no major
complications were noted. After laparoscopy, one patient
experienced a paralysis of the obturator nerve but was
recovered completely after 3 months. Another patient
Table 1 Body mass index (BMI), blood loss, number of recovered
lymph nodes, and hospital stay
Group 1
(laparotomy)
Group 2
(laparoscopy)
p-Value
FIGO 1 ? 2 (%) 89 89 NS
FIGO 3 (%) 11 10.5 NS
FIGO 4 (%) 0 0.5 NS
Operating time (min) 150 165 NS
Blood loss (ml) 580 240 \0.001
BMI (kg/m2) 29.6 31.6 NS
Recovered lymph
nodes (n)
18.1 21.2 \0.05
Postoperative hospital
stay (days)
13.2 5.6 \0.001
FIGO International Federation of Gynecology and Obstetrics staging;
NS not significant
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experienced a symptomatic lymphocele after laparoscopy,
which required laparoscopic marsupialization after three
unsuccessful trials of drainage that was ultrasonographi-
cally guided. In both groups, intraoperative staging showed
an advanced FIGO stage ([2) in 11% of cases.
Figure 1 shows the rate of conversion from laparoscopy
to laparotomy depending on the BMI. In group 1, 31
(25.8%) of the patients had a BMI higher than 30 kg/m2,
and 18 (15%) of these had a BMI exceeding 35 kg/m2, with
a maximal BMI of 50.2 kg/m2. When patients with a BMI
higher than 30 kg/m2 were analyzed separately, we could
not see a correlation between BMI and rate of conversion
to laparotomy, between BMI and blood loss, or between
BMI and the number of recovered lymph nodes. The
operating time for the patients with a BMI greater than
30 kg/m2 was statistically longer than for those with a BMI
less than 30 kg/m2 (170 vs 202 min; p = 0.0184).
A conversion to laparotomy was necessary in 6 (5%) of
the 120 cases managed by laparoscopy. For no patient was
the conversion to laparotomy due to obesity (Fig. 1). For
five patients, conversion was performed because of hem-
orrhage. In one case, the conversion was performed after
evidence of intraperitoneal tumor dissemination.
Discussion
As the prevalence of overweight and obese women con-
tinues to rise, an increased incidence of endometrial cancer
may be expected in this patient population. In addition to an
increased risk of endometrial cancer, these patients are at an
increased risk for medical comorbidities including diabetes
and cardiovascular diseases. Consequently, interest has
focused on identifying surgical techniques that may provide
adequate surgical treatment for this patient population while
minimizing surgical morbidity and mortality.
Increasing numbers of gynecologic oncologists are
suggesting laparoscopy as an alternative for their patients
with endometrial cancer [11–14]. Concerns about adequacy
of staging, a lack of long-term survival and recurrence data,
the learning curve, and prolonged operative times have
prevented the wide acceptance of laparoscopy. Because
many gynecologists believe obesity precludes laparoscopic
staging, they do not offer minimally invasive surgery to
obese patients. However, despite the limited number of
studies supporting the advantages of laparoscopy, growing
evidence shows that the minimally invasive procedure
offers adequacy of staging, reasonable operating times, less
blood loss, and a shorter hospital stay compared with lap-
arotomy [15–17].
Eisenhauer et al. [17] compared the outcomes of obese
women undergoing various surgical procedures for the
management of endometrial carcinoma. These authors
concluded that laparoscopic staging and panniculectomy at
the time of laparotomy were associated with a better lymph
node count and a lower rate of incisional complications
than laparotomy alone. In their study, the length of hospital
stay was 3 days for the patients treated laparoscopically.
The current study shows a significantly improved length
of hospital stay for the women in the laparoscopic group.
However, the hospital stay of 6 days this is longer than in
the aforementioned study [17]. The length of stay may be
due to the postoperative pathway at the time of the study,
which involved prolonged Foley catheter use and diet
restrictions that that have been changed in the meantime.
Several articles are available regarding the laparoscopic
treatment of early endometrial cancer [8, 9, 11]. A ran-
domized study by Zullo et al. [18] has confirmed the lap-
aroscopic approach to be a feasible and safe procedure for
the treatment of stage 1 endometrial cancer. These results
also are supported by our findings, although the main weak
point of our study probably is the retrospective design,
which we need to stress explicitly. This makes the current
paper more open to bias and may explain why our results
are rather equivalent, involving possible difficulties with
data collection, although the latter actually was not a
problem in our series.
Indeed, laparoscopic surgery currently is replacing
classical laparotomy in the management of early-stage
endometrial cancer. Our study and previous publications
that analyzed perioperative morbidity or validated the
laparoscopic method of examining the safety and extending
oncologic staging, including the number of harvested
lymph nodes during the procedure, have demonstrated
results similar to those for laparotomy. Additionally, other
advantages such as a shorter hospital stay and immediate
Fig. 1 Patients operated by laparoscopy (%) and BMI with the rate of
conversion to laparotomy
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increased postoperative quality of life are clearly in favor
of the laparoscopic approach [5, 18].
However, different authors report limitations of lapa-
roscopy for patients with a high BMI [6, 19], which would
be a major drawback of the technique, especially consid-
ering that these patients are at risk for the development of
endometrial cancer. Our data support the contrary, showing
that endometrial cancer in severely obese women can be
managed safely by laparoscopy. Neither the conversion
rate nor the complication rate was higher for this specific
group.
In the laparoscopic group, 31 (25.8%) patients had a
BMI higher than 30 kg/m2, and 18 (15%) of these had a
BMI exceeding 35 kg/m2, with a maximal BMI of 50.2 kg/
m2 (Fig. 1). A conversion to laparotomy was necessary in 6
(5.0%) of the 120 cases managed by laparoscopy. In none
of these cases was the conversion to laparotomy due to
obesity. It was due to hemorrhage in five cases and tumor
stage in one case. Although these indications for laparos-
copy were new, no major complications occurred, which
supports the safety of the laparoscopic approach.
These results need to be interpreted with caution
because of the study’s retrospective design. In a prospec-
tive study, we might have been able to identify minor
complications more easily. Minor complications may be
underreported because they were not considered suffi-
ciently important to be noted explicitly or because patients
with minor complications may have contacted their general
practitioner or referring gynecologist.
A retrospective approach may imply difficulties in data
collection. However, because we examined clearly defined
outcome measures, this was not a problem we consider
very significant.
Four different surgeons performed the interventions,
which may have led to a variation in outcomes. However,
because all the surgeons used the same technique recom-
mended by the Swiss group of endoscopic surgeons, the
surgical techniques are comparable. Additionally, it was
possible to use validated quality-of-life and pain ques-
tionnaires for the immediate postoperative and recovery
period to determine patient preferences for either approach,
particularly in this elderly patient group. This subject will
be addressed in future studies.
The blood loss in the group of patients with a BMI
exceeding 30 kg/m2 (168 ml) was not statistically higher
than in the group with a BMI lower than 30 kg/m2
(190 ml). The median number of recovered lymph nodes
(n = 21) demonstrates sufficient surgical staging [20] that
provided accurate information on the stage of disease. The
key to sufficient surgical staging is a team fully trained in
the management of endometrial cancer because increased
surgical experience improves the number of recovered
lymph nodes, as shown by Barakat et al. [21].
Our results and recent data suggest the comparability of
laparotomy and laparoscopy in terms of oncologic safety
for the treatment of early stage endometrial cancer [5, 22,
23]. A recent prospective trial [24] found a higher vaginal
cuff recurrence rate for patients treated with laparoscopic
surgery than for those treated with a laparotomy approach,
although this difference did not reach statistical signifi-
cance. In this regard, the latter finding seems to be in
agreement with a previous study [25], although there is no
unanimous consensus [25–27].
Because the surgeons participating in this study were
already experienced in laparoscopic surgery, our results
demonstrate that with appropriate experience in endoscopic
and oncological surgery, endometrial cancer can be treated
by laparoscopy without the need for a long learning curve
[28]. When our first 120 consecutive cases of laparoscop-
ically treated patients were compared with an age- and
tumor-matched historical group, the operation time and the
number of recovered lymph nodes were similar in the two
groups.
The current study supports the laparoscopic approach
for endometrial cancer in elderly and obese patients. Future
prospective studies will include validated pain and quality-
of-life scores as well as oncologic and cosmetic outcomes.
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